Presentation TCT 2017 What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes? Presenter: Azeem Latib, Dean J. Kereiakes October 31, 2017
Presentation TCT 2017 Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption Presenter: Azeem Latib, Bernard R. Chevalier October 31, 2017
Presentation TCT 2017 ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings Presenter: Azeem Latib, Manel Sabate October 31, 2017
Presentation TCT 2017 New Insights From AIDA: Subgroups and Predictors of Adverse Events Presenter: Azeem Latib, Joanna J. Wykrzykowska October 31, 2017
Presentation TCT 2017 Case Presentation: My Worst Bifurcation Mistake Presenter: Antonio Colombo, Manuel Pan, Azeem Latib October 30, 2017
Presentation TCT 2017 Cardioband Direct Annuloplasty for Functional MR: Procedure and Tips and Tricks Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Azeem Latib October 30, 2017
Presentation TCT 2017 Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion) Presenter: David Erlinge, Niels R. Holm, Azeem Latib October 30, 2017
Presentation TCT 2017 Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions Presenter: Antonio Colombo, Samir R. Kapadia, Azeem Latib October 29, 2017
Presentation TCT 2017 Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years? Presenter: Antonio Colombo, Azeem Latib, Jason H. Rogers October 29, 2017
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Industry News Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities July 11, 2017
News Industry News Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair June 16, 2017
Presentation TVT 2017 Transcatheter Tricuspid Repair of Patient With Severe TR and Mitral Stenois Presenter: Azeem Latib, Christopher U. Meduri June 15, 2017
Presentation TVT 2017 Transcatheter Treatment of a Patient With Severe Tricsupid Regurgitation With a Pacemaker Lead Presenter: Azeem Latib, Christopher U. Meduri June 15, 2017
Presentation TVT 2017 Thrombosed Mechanical Tricuspid Valve Emergent Valvuloplasty as Rescue Presenter: Azeem Latib, Christopher U. Meduri, Kashish Goel, MD June 15, 2017
Presentation TVT 2017 When Treating the Right Is Right: Successful Percutaneous Treatment of Tricuspid Stenosis/Regurgitation and Paravalvular Valvular Leak Presenter: Azeem Latib, Christopher U. Meduri, Moses Mathur, MD June 15, 2017
Presentation TVT 2017 MitraClip for Degenerative Tricuspid Regurgitation Presenter: Azeem Latib, Christopher U. Meduri, Remi Kouz, MD June 15, 2017
Presentation TVT 2017 Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure Presenter: Azeem Latib, Christopher U. Meduri, Elliott Groves, MD June 15, 2017